On the other hand, regorafenib-mediated activation of AMPK in HCC cells was presumably consequence of the energy stress caused by the perturbation of mitochondrial function, as previously demonstrated for sorafenib in breast cancer cells (24). The gene discussed is PRKAA1; the disease is breast cancer.